Allied Health & Imaging · Independent exam preparation
VA-BC Vascular Access Decision Guide Study Guide
Practise vascular access selection, vessel preservation, aseptic insertion, maintenance and complication assessment through focused clinical decisions and cases.
By CertMedbry · Updated 30 October 2026
Choose access that fits the therapy, preserve future vascular options, distinguish device malfunction from patient complications, and act on early signs of harm. This guide develops those decisions across all eight VACC domains. Its 60 concepts are selective; the complete official 2025 approved test specification defines the examination's full scope, including specialized devices and techniques beyond these examples.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination and professional level does this guide address?
This guide addresses the Vascular Access Certification Corporation's Vascular Access Board Certified examination, also styled Vascular Access-Board Certified or VA-BC. VACC describes it as assessing the basic knowledge, skills and abilities expected of professionals working in vascular access. The styling variations identify the same credential, not separate RN, NP or modality examinations.
How many questions are administered, and how many count toward the score?
The examination contains 150 four-option multiple-choice questions. Of these, 125 are scored and 25 do not contribute to the score. The detailed specification allocates the 125 scored items across eight domains. These independently authored practice questions are learning drills and do not predict a passing result.
About the Exam · 2025 Job Analysis: Appendix K. Approved Test Specification
How much examination time is provided?
VACC allows two and one-half hours for the examination. A separate 15-minute tutorial precedes it, and a separate 15-minute survey follows it. Those activities are additional to the examination time.
How is the examination delivered, and is it adaptive?
VACC lists Prometric test-center delivery and ProProctor remote proctoring. Test centers include US and Canadian locations and selected international sites. VACC describes a 150-question multiple-choice examination without identifying it as computer adaptive. Remote candidates should complete the required system check before scheduling.
Which item styles and cognitive levels are verified?
Each examination item has four possible answers. The official outline identifies recall, application and analysis as the cognitive levels. VACC's published format describes four-option multiple-choice items. The questions in this guide use four-option single-best-answer decisions.
Which blueprint applies, and what are its domain weights?
The current issuer outline is based on the 2025 practice analysis. Its weights are Device Assessment and Selection 14%; Patient Assessment 18%; Preparation 11%; Insertion 11%; Care and Maintenance 14%; Troubleshooting Complications and Interventions 16%; Professional Development and Evidence-Based Practice 8%; and Legal and Ethical Considerations 8%. The corresponding scored-item allocations are 17, 23, 14, 14, 17, 20, 10 and 10.
Detailed Content Outline · 2025 Job Analysis: Appendix K. Approved Test Specification
What dates and handbook inconsistencies should candidates understand?
The issuer pages and standalone specification available on October 30, 2026 identify the 2025 practice analysis as the current basis. The standalone specification does not print an exact implementation date. The 2026 handbook expires December 31, 2026; that is not a blueprint effective date. Its historical 2020-analysis paragraph and incomplete summary table should be read alongside the complete eight-domain specification on printed pages 21 and 22 and the current issuer outline.
Detailed Content Outline · 2025 Job Analysis: Appendix K. Approved Test Specification · Vascular Access Certification and Recertification Candidate Handbook 2026
Which language, jurisdiction and certification period apply?
VACC states that the examination is available only in English and uses US-based references reflecting US clinical practice. International testing availability does not convert those references into another jurisdiction's legal rules. VACC states that successful candidates hold VA-BC certification for three years before renewal.
How completely do the guide, questions and flashcards represent the outline?
All eight domains appear, with emphasis approximating the published weights. The 60 concepts, 20 questions and 20 flashcards are selective learning resources. They do not replace the complete outline, reproduce secure examination items or establish readiness through a predicted passing score. Use the official specification to identify additional study needs.
VA-BC is VACC's specialty certification for vascular access professionals. This independently authored guide supports that credential's US-practice knowledge scope; it is not an official VACC preparation product or a separate nursing licensure or advanced-practice examination.
Outline used: Current VACC 2025 Job Analysis, Appendix K: Approved Test Specification, verified on 2026-10-12. Corroborated by the 2026 Certification and Recertification Candidate Handbook, which expires 2026-12-31. The standalone outline does not state an exact implementation date. The workbook label maps to this examination; VACC also uses the styling Vascular Access-Board Certified™.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Device Assessment and Selection14%
1.What makes a PICC a central venous device?
A peripherally inserted central catheter enters through a peripheral vein but terminates in the central venous circulation. Classification therefore depends on the intended and confirmed tip location, rather than the skin entry site. This distinction matters because therapy suitability depends on where the infusate enters the bloodstream. Before first use, the prescribed tip-location confirmation must be completed and documented; an arm insertion alone establishes neither central placement nor readiness for therapy.
Apply it
A patient needs an infusate unsuitable for peripheral administration. The proposed catheter enters an upper-arm vein. You verify that it is a PICC and review documented central tip confirmation before accepting it for treatment.
Common pitfall: Calling every arm catheter peripheral overlooks the distal tip. Conversely, calling a device a PICC does not establish that its current tip position is acceptable.
2.Why does a midline remain peripheral access?
A midline provides peripheral venous access despite being longer than a short peripheral catheter and often entering through the upper arm. Its name, length and power-injection capability do not make its tip central. Evaluate the planned therapy for peripheral compatibility before choosing it. The manufacturer's description of a PowerMidline as peripheral access illustrates why device branding or insertion technique cannot substitute for understanding the intended tip location and permissible uses.
Apply it
A referral requests a midline for a solution identified as unsuitable for peripheral veins. You explain that the proposed device remains peripheral and collaborate on an access plan compatible with the prescribed infusion.
Common pitfall: Greater catheter length does not confer central-infusion suitability. A power-injectable peripheral device also remains subject to peripheral therapy limitations and its specific instructions.
3.How should therapy requirements guide peripheral versus central selection?
Select the access location by combining infusate characteristics, administration method, anticipated duration and patient vascular options. A brief treatment can still require central administration when the prescribed solution is unsuitable for peripheral veins. Conversely, prolonged treatment does not automatically justify a central catheter when a suitable peripheral plan exists. The decisive issue is whether the device can deliver the actual therapy safely throughout the intended course, with an acceptable burden of complications and maintenance.
Apply it
Two patients each need several days of treatment. One has a peripherally compatible medication; the other's prescribed infusion requires central administration. You develop different device plans despite their similar treatment durations and discharge dates.
Common pitfall: Choosing solely from a duration table can miss an infusate restriction. Treatment length informs selection but cannot override the required route of administration.
4.Why should a catheter have only the necessary lumens?
Each additional lumen adds access points and opportunities for manipulation, so CDC recommends using the minimum number of ports or lumens essential for patient management. Determine actual simultaneous infusion needs, incompatibilities and required functions before ordering a device. A larger lumen count is justified by a defined treatment requirement, not by convenience or hypothetical future use. Reassess whether medication scheduling or another safe administration arrangement can meet the same clinical need.
Apply it
A stable patient requires one continuous compatible infusion and no other essential central-access function. A triple-lumen catheter is requested for flexibility. You clarify the treatment plan and recommend the minimum lumen count that meets it.
Common pitfall: More lumens can appear to prevent future procedures, but an unused lumen still creates maintenance work and exposure without a demonstrated treatment benefit.
Summary of Recommendations: Intravascular Catheter-Related Infections
5.How do an implanted port and an external catheter differ for long-term treatment?
An implanted port lies beneath the skin and requires a non-coring needle for access. Once the incision has healed and the port is deaccessed, no catheter or access needle remains outside the body; maintenance between treatments is generally less frequent. A tunneled external catheter offers access without repeated skin puncture but retains external tubing and an exit site requiring protection and ongoing care. Frequent or continuous treatment may favor ready external access, whereas intermittent treatment and activities may favor a port.
Apply it
For intermittent treatment over many months, a patient prioritizes swimming and avoiding external tubing. You discuss a port as a potentially suitable option after healing and when deaccessed. You also explain needle access, insertion and removal procedures, and maintenance. External access retains tubing and exit-site protection needs.
Common pitfall: A port does not eliminate maintenance. Its activity advantages depend on healing and access status; an accessed port has a needle, external connection and dressing that must be protected.
Central venous access devices · Summary of Recommendations: Intravascular Catheter-Related Infections
6.Why should a dialysis catheter not be treated as interchangeable general access?
A specialized catheter must be evaluated against its intended treatment function and device instructions. Central tip location alone does not establish that every proposed use is appropriate. Identify the catheter and clarify its authorized functions before planning additional connections or procedures. Unnecessary manipulation also creates contamination opportunities, so a convenient available lumen is not sufficient justification for additional use. In patients receiving or approaching hemodialysis, selection must additionally preserve future access; CDC advises avoiding subclavian access because of stenosis risk.
Apply it
A patient has a dialysis catheter and needs another infusion. You establish the device's permitted functions and coordinate the access plan with the treating team rather than assuming that any central lumen is available for general therapy.
Common pitfall: Do not infer a specialized catheter's permissible uses from its appearance or central location. Protecting the current treatment function and future vascular options both matter.
2025 Job Analysis: Appendix K. Approved Test Specification · Summary of Recommendations: Intravascular Catheter-Related Infections · Central venous access devices
7.Which checks establish whether a device can support power injection?
Power injection requires verified compatibility of the specific catheter, selected lumen and connected components with the planned injection conditions. Confirm device identity and the applicable manufacturer's instructions rather than inferring suitability from the term PICC or from connector appearance. Pressure or flow ratings are device specific. An otherwise functional catheter should not be used for an intended injection when the required identification or compatibility information is unavailable, or when damage is suspected.
Apply it
Imaging requests power injection through an established PICC, but the transfer record lacks its model and lumen information. You obtain the device identification and applicable instructions before deciding whether that access can support the study.
Common pitfall: A central catheter is not automatically power injectable. Compatibility of one catheter component does not establish compatibility of the entire proposed injection pathway.
Central venous access devices · Intravascular PICC Catheter Recall: Bard Removes PowerPICC Intravascular Catheters
8.How should securement and connector compatibility influence device planning?
Securement, dressings and connectors function as a system with the catheter. CDC recommends ensuring that system components are compatible to minimize leaks and breaks, and recommends sutureless securement to reduce infection risk. Select supplies that stabilize the device without damaging its material or preventing site assessment. A familiar product is not automatically appropriate for every catheter. Review the relevant instructions when changing connector types, securement methods or other components of an established system.
Apply it
A supply substitution would attach a different connector and securement product to an existing catheter. Before accepting the substitution, you check compatibility and whether the arrangement maintains stabilization, connection integrity and appropriate site observation.
Common pitfall: Treating connectors and securement as interchangeable accessories can create leaks, disruption or catheter damage even when each component is acceptable for another device.
Summary of Recommendations: Intravascular Catheter-Related Infections
Patient Assessment18%
9.How does medical history change the vascular access assessment?
Medical history identifies constraints that a visually attractive vein cannot reveal. Prior thrombosis, vascular procedures, renal disease, previous catheter complications and relevant laboratory results can alter the available sites, procedural risk or need for additional evaluation. Integrate these findings with the current therapy and urgency. Laboratory values require clinical interpretation rather than an invented universal insertion threshold. A complete assessment explains why a proposed device is appropriate for this patient, rather than merely technically insertable.
Apply it
A visible upper-arm vein appears suitable, but the patient reports previous thrombosis on that side and repeated access failures. You review the history and relevant imaging before accepting that vessel for another device.
Common pitfall: A good surface appearance does not cancel a significant vascular history. A single laboratory result also cannot independently establish overall procedural suitability.
2025 Job Analysis: Appendix K. Approved Test Specification · Central venous access devices
10.Which details of an infusion must be assessed before selecting access?
Assess the actual prescribed preparation and administration plan, including concentration, vesicant or irritant potential, peripheral compatibility, delivery pattern and expected duration. The drug name alone may not describe the vascular exposure because formulations and administration conditions can differ. Resolve incomplete therapy information with the prescribing and pharmacy teams before choosing access. A catheter's technical ability to carry fluid does not establish that the surrounding vein can tolerate the intended infusate safely.
Apply it
A referral lists only an antimicrobial name and requests durable access. You obtain the planned formulation, administration schedule and treatment duration, then evaluate peripheral compatibility and patient factors before recommending a catheter.
Common pitfall: Memorizing a drug name without its administration context can produce an inappropriate device recommendation. A longer catheter does not correct peripheral incompatibility.
11.How is catheter-to-vein ratio measured and interpreted for PICC planning?
Calculate the diameter ratio as catheter outer diameter divided by vein internal diameter, multiplied by 100, using the same units. Measure the vein with ultrasound at the proposed insertion site without a tourniquet. eviQ recommends a ratio below 45% for PICC planning to reduce thrombosis risk. This is a clinical recommendation, not a numerical rule issued by VACC. The adult PICC evidence does not establish a universal threshold for neonates or every vascular device. Use the catheter's actual outer diameter where it will occupy the vessel.
Apply it
An adult's vein measures 4.0 mm without a tourniquet, and the proposed PICC has a 1.7 mm outer diameter at the relevant segment. The ratio is 1.7 divided by 4.0 multiplied by 100, or 42.5%. A 2.0 mm catheter would produce 50%, prompting consideration of a smaller suitable catheter or another vessel.
Common pitfall: Do not divide French size directly by a vein diameter in millimeters. This diameter ratio does not describe the percentage of cross-sectional area occupied, and a favorable result does not eliminate thrombosis risk.
Central venous access devices · 2025 Job Analysis: Appendix K. Approved Test Specification
12.How should previous access failure guide the next assessment?
Repeated failure should trigger investigation of the failure pattern, not simply another insertion. Review whether previous devices failed through infiltration, dislodgement, occlusion, infection or suspected thrombosis, and compare those mechanisms with the proposed device and site. Repeated use of the same unsuccessful strategy can consume vascular options without correcting the underlying problem. Device-performance information becomes useful when it changes selection, securement, maintenance support or the need for further vascular assessment.
Apply it
Three peripheral catheters have failed near a frequently flexed joint during the same treatment course. You review the failure circumstances and consider a different site, stabilization approach or suitable device rather than repeating the placement.
Common pitfall: Counting successful insertions alone can hide poor device survival. Repeated replacement is not an adequate response when the same preventable failure mechanism persists.
2025 Job Analysis: Appendix K. Approved Test Specification · Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update
13.Why does advanced kidney disease require a vessel-preservation plan?
Patients who may require hemodialysis need assessment that considers future vascular access as well as today's infusion. CDC recommends avoiding the subclavian site in hemodialysis patients and those with advanced kidney disease because of subclavian vein stenosis risk. Discuss proposed access with the relevant team when future dialysis access may be affected. Immediate convenience should not consume an important vascular option without considering the patient's longer-term renal treatment needs.
Apply it
A patient with advanced kidney disease needs several days of intravenous treatment. Before approving a convenient central site, you review the renal access plan and discuss an option that protects future dialysis access.
Common pitfall: Choosing solely for immediate insertion ease can create lasting vascular consequences. Avoid assuming that a short treatment course makes future dialysis considerations irrelevant.
Summary of Recommendations: Intravascular Catheter-Related Infections
14.How should antiseptic and adhesive reactions be assessed?
Clarify what product caused the previous reaction, its timing, the symptoms and whether the problem involved antiseptic, adhesive or another component. These histories lead to different prevention plans. An antiseptic contraindication requires an appropriate alternative; adhesive injury may require a different securement or dressing strategy. CDC lists alternatives when chlorhexidine is contraindicated. Recording only an imprecise label such as dressing allergy can leave the next clinician unable to choose safe supplies.
Apply it
A patient reports an allergy after a previous central-line dressing. You ask whether the reaction followed skin preparation or adhesive contact, review the documented symptoms, and arrange supplies that address the identified problem.
Common pitfall: Treating every redness episode as the same allergy can lead to unnecessary product avoidance while leaving the actual cause of injury in use.
Summary of Recommendations: Intravascular Catheter-Related Infections
15.How do cognitive and developmental needs change device planning?
Assess whether the patient can understand the procedure, report symptoms, protect the access and participate in maintenance. Developmental stage or cognitive impairment may change teaching methods, supervision needs and the support required to keep a device safe. These findings do not automatically determine one catheter type. Instead, they identify practical risks and resources that must be addressed in the plan. Use demonstration and teach-back with the patient or responsible caregiver to test understanding.
Apply it
A patient with memory impairment repeatedly handles external tubing and cannot recall reporting instructions. You involve the caregiver, assess supervision and adapt the education and access plan before assuming independent device care is feasible.
Common pitfall: Providing the usual leaflet does not establish understanding or safe self-care. Cognitive impairment also does not justify excluding the patient from appropriate explanations and participation.
Use the Teach-Back Method: Tool 5 · 2025 Job Analysis: Appendix K. Approved Test Specification
16.Which communication needs should be identified during assessment?
Identify the patient's preferred language, communication method and ability to understand the planned discussion. Language proficiency should not be inferred from conversational small talk or a relative's presence. AHRQ recommends qualified healthcare interpreters when needed because accurate communication supports history-taking, informed decisions and symptom reporting. Also ask about cultural or personal concerns that affect the plan, using the patient's own explanation rather than assumptions based on group identity or appearance.
Apply it
A patient answers simple greetings in English but cannot explain the planned catheter procedure. You identify the preferred language, arrange qualified interpretation and explore the patient's concerns before relying on the apparent conversational fluency.
Common pitfall: A relative's assurance that the patient understands is not a substitute for assessing communication needs. Avoid equating limited English proficiency with limited decision-making ability.
17.How do home-care resources affect device suitability?
An access plan must remain workable after the insertion encounter. Assess who will perform care, whether supplies and follow-up are available, how concerns will be reported and whether the patient or caregiver can demonstrate essential tasks. A device that meets infusion requirements can still fail if its maintenance is unsupported. Identify specific gaps early enough to arrange services, adapt teaching or reconsider an otherwise appropriate treatment-delivery plan with the care team.
Apply it
A patient can receive treatment at home but has no dressing supplies and cannot demonstrate protecting the catheter during daily activities. You address those gaps with case management before treating discharge readiness as established.
Common pitfall: Successful insertion does not establish a safe outpatient plan. An instruction sheet cannot replace missing supplies, follow-up access or the ability to perform required care.
2025 Job Analysis: Appendix K. Approved Test Specification · Use the Teach-Back Method: Tool 5
18.How should imaging be matched to the assessment question?
Choose imaging according to the uncertainty that must be resolved. Finding a superficial vein, evaluating a suspected vascular obstruction and confirming a central catheter tip are different tasks. One image does not automatically answer all three. The official outline includes ultrasound, transillumination, venography and chest imaging because vascular assessment extends beyond surface visibility. Before requesting or interpreting a study, state the clinical question and determine whether the selected method can provide the required information.
Apply it
An upper-arm vein is visible on ultrasound, but the patient has a history suggesting central venous obstruction. You recognize that local vessel visualization does not establish an unobstructed central pathway and seek appropriate further assessment.
Common pitfall: A reassuring local image can be overextended into a conclusion about the entire venous route. Distinguish vessel identification from central patency and tip-location assessment.
2025 Job Analysis: Appendix K. Approved Test Specification · Central venous access devices
19.Why establish baseline symptoms before inserting a device?
Baseline assessment helps distinguish a pre-existing problem from a new insertion-related change. Document relevant pain, swelling, skin condition and reported sensory symptoms before the procedure, then compare later findings with that baseline. This comparison supports timely recognition of deterioration without assuming that every subsequent complaint was caused by the catheter. Baseline information also helps the next clinician interpret changes during treatment. Record the location and character of findings rather than using an uninformative statement such as assessment normal.
Apply it
Before insertion, a patient describes intermittent tingling in the proposed limb. You document its distribution and timing, discuss its relevance to the plan, and reassess if a new or different sensation occurs during the procedure.
Common pitfall: Without a baseline, a new clinician may dismiss a true change or attribute longstanding symptoms to the device. Vague documentation cannot support reliable comparison.
2025 Job Analysis: Appendix K. Approved Test Specification · Central venous access devices
Preparation11%
20.How should the care team resolve an incomplete access request?
An access request should be translated into a complete clinical plan before insertion. Clarify the therapy, route requirements, expected use, patient risks and maintenance arrangements with the relevant team members. Pharmacy may resolve infusate compatibility, case management may address home-care support, and specialist input may protect future vascular options. Collaboration is useful when it changes a concrete decision. Proceeding with an inadequately specified device request can create a technically successful insertion that fails the patient's treatment needs.
Apply it
The order requests a PICC without explaining the planned infusion or discharge needs. You clarify those requirements with the treating team and case manager before selecting the device, lumen count and maintenance arrangements.
Common pitfall: Treating an order's device name as a complete assessment can bypass unresolved therapy and patient questions. Collaboration should produce an actionable plan rather than additional signatures.
2025 Job Analysis: Appendix K. Approved Test Specification · Central venous access devices
21.Why are hand hygiene and aseptic technique both necessary?
Hand hygiene reduces organisms carried on hands, while aseptic technique protects prepared sites and critical device surfaces from contamination. Neither function is replaced by wearing gloves. CDC recommends hand hygiene before and after palpating insertion sites and before and after inserting, replacing, accessing, repairing or dressing intravascular catheters. After skin antisepsis, avoid touching the site unless aseptic technique is maintained. Plan the workspace so that clean preparation is not undone by later contact with contaminated objects.
Apply it
After preparing equipment, a clinician adjusts a nonsterile bedside object and reaches toward the insertion field. You identify the contamination opportunity and restore appropriate hand hygiene and barriers before the next critical task.
Common pitfall: Gloves can carry contamination just as hands can. Performing hand hygiene once at the start does not protect every later access or dressing task.
Summary of Recommendations: Intravascular Catheter-Related Infections
22.How should skin antisepsis be completed before central catheter insertion?
CDC recommends preparing clean skin with a chlorhexidine preparation containing more than 0.5% chlorhexidine in alcohol before central venous and peripheral arterial catheter insertion, unless contraindicated. Appropriate alternatives exist when chlorhexidine cannot be used. Allow the antiseptic to dry according to its manufacturer's recommendations before puncture. Drying is part of the preparation process, not optional waiting time. Patient age and product restrictions also matter; adult recommendations should not be indiscriminately extended to neonates.
Apply it
An adult's central-line site has just been prepared with the selected antiseptic. The operator is ready to puncture while the skin remains wet. You ensure the required drying is completed before proceeding.
Common pitfall: Using the correct antiseptic does not compensate for incomplete application or drying. A known contraindication requires an appropriate alternative rather than simply omitting skin antisepsis.
Summary of Recommendations: Intravascular Catheter-Related Infections
23.Which barriers are required for central venous catheter insertion?
For CVC and PICC insertion and guidewire exchange, CDC recommends maximal sterile barrier precautions: cap, mask, sterile gown, sterile gloves and a sterile full-body drape. These measures reduce opportunities for microorganisms to reach the insertion site or equipment during the procedure. Sterile gloves and a small fenestrated drape alone do not constitute the full barrier arrangement. Confirm the setup before beginning so that missing protection is corrected before critical supplies or the prepared site are exposed.
Apply it
A PICC insertion tray includes sterile gloves and a small drape, but no gown or full-body drape has been arranged. You complete maximal sterile barrier preparation before allowing the insertion to begin.
Common pitfall: Peripheral entry does not exempt a PICC from central-line insertion precautions. A small sterile field is not equivalent to the required full-body drape.
Summary of Recommendations: Intravascular Catheter-Related Infections
24.How should an interpreter support procedural preparation?
Use a qualified healthcare interpreter when language differences prevent reliable communication about the procedure. Speak directly to the patient, present information in manageable segments and verify understanding through the interpreter. AHRQ cautions against relying on unqualified family members because omissions, interpretation errors and inhibited disclosure can compromise the conversation. Interpretation supports the patient's own decision; it does not transfer the decision to the interpreter or family. Arrange this support before consent and procedural explanations are treated as complete.
Apply it
A patient's adult child offers to translate the catheter discussion but repeatedly answers instead of interpreting. You arrange qualified interpretation and address the patient directly while preserving the family's appropriate supportive role.
Common pitfall: Family availability does not establish interpreting competence. A translated consent form alone cannot replace an understandable discussion of the procedure, alternatives and patient questions.
Address Language Differences: Tool 9 · Informed Consent: AMA Code of Medical Ethics, Opinion 2.1.1
25.How do consent and a procedural time-out address different risks?
Informed consent supports an understandable, voluntary decision about the proposed intervention, its expected benefits, burdens and alternatives. A procedural time-out checks the immediate procedure plan, including the correct patient and intended intervention and site. These functions complement one another: a signed consent does not verify the current setup, and a time-out does not create informed permission. The VACC outline includes both consent and time-out within preparation, making their distinct purposes important to clinical reasoning.
Apply it
The consent discussion concerned a left-sided device, but the prepared field is on the right. During the time-out, you identify the discrepancy and resolve the intended plan with the patient and team before insertion.
Common pitfall: A signature cannot settle a mismatch in the actual procedure plan. Conversely, confirming the patient and site does not prove that the decision was informed.
2025 Job Analysis: Appendix K. Approved Test Specification · Informed Consent: AMA Code of Medical Ethics, Opinion 2.1.1
26.How should positioning and comfort be planned before insertion?
Preparation should account for the patient's anatomy, mobility, respiratory tolerance, anxiety and ability to remain in the required position. Positioning and pain-management needs can affect whether the planned procedure is feasible and how safely it can be completed. The official outline includes repositioning, pain management, sedation and ergonomics, without prescribing one universal regimen. Identify limitations before sterile preparation and coordinate appropriate assistance or an alternative procedural arrangement rather than discovering an avoidable barrier after insertion has begun.
Apply it
A patient cannot tolerate the proposed position because of breathlessness and severe shoulder pain. You pause setup, discuss the limitations with the team and establish a tolerable position and comfort plan before preparing the field.
Common pitfall: A standard setup should not override an identified patient limitation. Sedation is not an automatic solution to every positioning or communication difficulty during insertion.
Insertion11%
27.Why does real-time ultrasound differ from marking a vessel beforehand?
A preliminary ultrasound scan identifies anatomy at one moment, whereas real-time guidance supports observation during needle advancement. CDC recommends ultrasound guidance for central venous catheter placement when available and used by trained personnel to reduce cannulation attempts and mechanical complications. A skin mark cannot show movement of the vessel, needle or surrounding structures during the puncture. Competence requires demonstrated image-guided insertion and aseptic equipment handling; recognizing a vessel or attending an equipment demonstration alone does not establish procedural competence.
Apply it
A clinician marks a vein with ultrasound, removes the probe and begins a difficult central puncture. You distinguish that preliminary mapping from real-time guidance and arrange appropriately trained support for the intended technique.
Common pitfall: An ultrasound scan before puncture is not the same as observing the needle during placement. Equipment availability alone does not establish operator competence.
Summary of Recommendations: Intravascular Catheter-Related Infections · Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update
28.How is asepsis maintained when ultrasound enters the insertion field?
Ultrasound improves visualization but introduces equipment that must be managed within the sterile procedure. Probe handling, the sterile cover, coupling medium and cable position must preserve the prepared field and critical supplies. The infection-prevention benefit of a careful insertion technique can be lost if nonsterile equipment contacts the site. Use the appropriate sterile ultrasound setup and maintain maximal sterile barriers for central catheter insertion; imaging guidance does not replace any of those protections.
Apply it
During ultrasound-guided insertion, an uncovered portion of the probe assembly approaches the prepared puncture site. You stop the contact risk and restore the appropriate sterile arrangement before continuing needle placement or handling sterile equipment.
Common pitfall: A sterile probe cover does not make every exposed cable or hand movement sterile. Ultrasound use adds field-management tasks rather than removing aseptic requirements.
Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update · Summary of Recommendations: Intravascular Catheter-Related Infections
29.What must tip confirmation establish for an upper-body PICC?
Navigation guides the catheter's course; confirmation establishes its final anatomic location. For an upper-body PICC, eviQ identifies the cavoatrial junction, where the superior vena cava meets the right atrium, as the preferred target with the greatest safety profile. Its guidance also accepts the lower third of the superior vena cava or upper right atrium, subject to applicable clinical and device requirements. Before first use, obtain and document an interpretable result establishing acceptable final tip location. An inconclusive result remains unresolved despite easy flushing, blood return or an expected insertion length.
Apply it
A navigation display shows a PICC entering the chest, but no interpretable final endpoint is recorded. You withhold the central-only infusion through that device and obtain valid location confirmation. If treatment cannot wait, the team arranges another suitable confirmed access plan.
Common pitfall: Reducing the infusion rate or giving a test dose cannot establish final tip anatomy. An acceptable upper-right-atrial location does not permit unrestricted advancement into the heart.
Central venous access devices · 2025 Job Analysis: Appendix K. Approved Test Specification
30.How do Seldinger and modified Seldinger techniques differ?
Seldinger insertion uses needle access, guidewire placement and dilation to permit catheter advancement. The micropuncture modified Seldinger approach described by the NSW Agency for Clinical Innovation uses a small access needle and a combined dilator-introducer to provide catheter entry. The modification concerns the access equipment and sequence. Terminology varies: ASA's 2020 guideline describes modified Seldinger as advancing a cannula over the needle, then passing the wire through that cannula. Identify the actual kit and sequence before proceeding. [NSW ACI, October 2021](https://aci.health.nsw.gov.au/__data/assets/pdf_file/0010/239626/ACI-CVAD-clinical-practice-guide.pdf); [ASA, 2020](https://doi.org/10.1097/ALN.0000000000002864).
Apply it
A kit contains a micropuncture needle and dilator-introducer assembly. You recognize the micropuncture modification and follow that kit's sequence rather than assuming that every procedure called modified Seldinger uses identical equipment.
Common pitfall: The technique name alone does not specify every procedural step. A smaller puncture needle does not eliminate risks from subsequent dilation or catheter advancement.
31.How should a recognized sterile-field breach change insertion?
A sterile-field breach requires correction before the affected equipment or site is used further. Identify what became contaminated, replace or reprepare the affected elements and restore the required barriers. Continuing because the breach was brief does not remove the contamination opportunity. Infection-prevention programs should empower observers to identify unsafe practice and interrupt it. The relevant decision is whether asepsis has been restored, rather than whether the procedure is almost finished or restarting part of the setup is inconvenient.
Apply it
A sterile catheter segment touches a nonsterile surface immediately before advancement. You identify the breach, prevent use of the contaminated segment and restore the sterile setup before the insertion proceeds further.
Common pitfall: A quick wipe is not a universal remedy for contaminated sterile insertion equipment. The small duration of contact does not establish that the item remains sterile.
Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update · Summary of Recommendations: Intravascular Catheter-Related Infections
32.When is guidewire exchange inappropriate for a non-tunneled catheter?
CDC advises against guidewire exchange to replace a non-tunneled catheter when infection is suspected. Reusing the established tract does not resolve the concern that the catheter or insertion pathway may be contaminated. Guidewire exchange may have a role for a malfunctioning non-tunneled catheter when there is no evidence of infection, but those are different circumstances. Before choosing an exchange technique, distinguish mechanical malfunction from an infection concern rather than assuming that all replacement indications are equivalent.
Apply it
A non-tunneled central catheter malfunctions and the team is also investigating catheter-related infection. You question a proposed guidewire exchange because the infection concern changes whether the existing route should be reused.
Common pitfall: Avoiding another puncture is attractive, but convenience does not make guidewire exchange appropriate when infection is suspected in a non-tunneled catheter.
Summary of Recommendations: Intravascular Catheter-Related Infections
33.How should inadvertent large-bore arterial cannulation be recognized and initially managed?
An arterial pressure waveform or imaging showing arterial placement signals a mechanical insertion emergency. Blood color and absence of pulsatile flow cannot establish venous placement. In an adult with an artery cannulated by a dilator or large-bore catheter, stop the procedure and infusions, leave the device in place and immediately consult a general surgeon, vascular surgeon or interventional radiologist for controlled removal and repair planning. Immediate bedside withdrawal can cause major hemorrhage or stroke. [ASA, 2020](https://doi.org/10.1097/ALN.0000000000002864).
Apply it
During intended internal jugular access in an adult, a newly placed large-bore catheter produces a systemic arterial waveform and ultrasound shows carotid placement. You stop use, leave it in place and obtain immediate specialist help.
Common pitfall: Do not apply a simple needle-puncture withdrawal approach to large-bore arterial cannulation. Easy blood return does not establish venous placement.
Care and Maintenance14%
34.What should routine insertion-site assessment establish?
Site assessment looks for local changes and incorporates the patient's symptoms, not merely whether the dressing remains attached. CDC recommends regular evaluation by palpation through the dressing or visual inspection when the dressing allows it. Tenderness, unexplained fever or other findings suggesting infection require a more complete examination. Ask about discomfort and changes during infusion because patients may notice problems before a scheduled check. Compare findings with the baseline and document specific observations that can guide subsequent decisions.
Apply it
A transparent dressing looks intact, but the patient reports new tenderness underneath it. You assess the complaint and inspect as indicated rather than recording a normal site solely because the dressing remains sealed.
Common pitfall: An intact dressing is a barrier assessment, not proof of a healthy insertion site. Patient-reported pain should not be dismissed because drainage is absent.
Summary of Recommendations: Intravascular Catheter-Related Infections
35.How do aspiration and injection findings describe lumen patency?
Patency assessment considers both the ability to aspirate and the ability to inject, together with resistance, symptoms and device history. A lumen may allow fluid entry while failing to yield blood, so flushing alone is an incomplete functional assessment. Follow the device-specific care plan and investigate unexpected changes. Do not force fluid against resistance. Recording the separate findings helps distinguish partial dysfunction from complete obstruction and directs further assessment rather than assigning every problem the same label.
Apply it
A central lumen accepts a gentle flush but no longer yields blood. You document both findings, check for associated symptoms and mechanical causes, and follow the patency assessment pathway instead of declaring the lumen fully functional.
Common pitfall: Easy injection does not prove normal aspiration or safe use for every therapy. Increasing force can conceal a problem while increasing the risk of damage.
Patency management algorithm for central venous access devices · Clinical procedure: Restoring patency to a central venous access device—partial and complete occlusion
36.Why must a needleless connector be disinfected before access?
A connector can transfer organisms into the fluid pathway when it is accessed. CDC recommends scrubbing the access port with an appropriate antiseptic and accessing it only with sterile devices. Follow the applicable product instructions for the disinfection process, including required contact and drying conditions. A connector's external appearance cannot establish microbiological cleanliness. Repeated accesses create repeated opportunities for contamination, so the procedure must be reliable at each access rather than performed only during a scheduled dressing change.
Apply it
A clinician prepares to attach a sterile syringe to a connector that looks clean but has not been disinfected for this access. You complete the required connector preparation before making the connection.
Common pitfall: A sterile syringe does not disinfect the surface it touches. A protective cap or recent access also should not be assumed to satisfy every product's instructions.
Summary of Recommendations: Intravascular Catheter-Related Infections · Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update
37.When should a catheter dressing be replaced before its scheduled change?
CDC recommends replacing a catheter dressing when it becomes damp, loose or visibly soiled. A scheduled interval does not justify leaving a compromised barrier in place. Evaluate the cause as well as replacing the dressing: leakage, bleeding, perspiration or poor adherence may require additional assessment or an adjusted care approach. Use aseptic technique and protect the catheter during the change. The decision is driven by dressing condition and patient findings, not simply the date written on the dressing.
Apply it
A central-line dressing was changed yesterday but is now damp and lifting at one edge. You arrange an aseptic replacement and assess the moisture source rather than waiting until the next routine change date.
Common pitfall: Adding tape over a compromised dressing can hide moisture or contamination. A recently applied dressing is not necessarily an effective barrier at the next assessment.
Summary of Recommendations: Intravascular Catheter-Related Infections
38.Which patients have a supported indication for chlorhexidine-impregnated dressings?
CDC's updated recommendation supports appropriately labeled chlorhexidine-impregnated dressings for adults with short-term, non-tunneled central venous catheters. The recommendation is population and device specific. Such dressings are not recommended for premature neonates because of the risk of serious adverse skin reactions. For other pediatric patients, the update identifies insufficient evidence for a general recommendation. Distinguish dressing selection from skin-antisepsis decisions, and do not transfer an adult dressing recommendation to every catheter type or age group.
Apply it
A unit proposes using its adult chlorhexidine dressing protocol unchanged for premature neonates. You identify the specific neonatal skin-injury concern and explain why the adult recommendation cannot support that extension to the proposed population.
Common pitfall: A product that prevents infection in one population may cause harm in another. Chlorhexidine dressing recommendations and chlorhexidine skin-preparation recommendations are separate questions.
Updated Recommendations on Chlorhexidine-Impregnated Dressings: Summary
39.How does teach-back establish whether device-care teaching worked?
Teach-back asks the patient or caregiver to explain key information in their own words, while demonstration checks performance of a practical task. AHRQ frames this as a test of how clearly the clinician explained the information, not a test of the patient. Teach a small amount, ask for an explanation or demonstration, correct gaps and check again. Agreement, a signature and asking whether someone understands do not reliably establish the ability to recognize problems or perform care.
Apply it
After teaching a caregiver when to report catheter problems, you ask them to describe what they would do if swelling developed during infusion. Their response reveals a gap, so you reteach and check again.
Common pitfall: A confident yes may reflect politeness rather than understanding. Correcting a teach-back error should improve the explanation instead of blaming or embarrassing the learner.
40.Which device information must follow the patient between care settings?
Continuity requires enough information for the receiving team to identify the device, understand its placement and restrictions, and continue its care safely. Transfer the insertion details, documented tip confirmation when applicable, relevant maintenance instructions and unresolved complications. Include device-specific information needed for proposed uses rather than relying on a generic statement that a central line is present. The VACC outline explicitly includes insertion information, maintenance instructions and patient restrictions within care planning across the healthcare continuum.
Apply it
A patient transfers with an established PICC and an infusion due soon. You ensure the receiving team has the device identification, tip-confirmation documentation, care instructions and current concerns before assuming treatment can continue safely.
Common pitfall: A handoff that names only the device type can omit crucial use restrictions or unresolved findings. Verbal reassurance cannot replace an accessible, accurate device record.
2025 Job Analysis: Appendix K. Approved Test Specification · Central venous access devices
41.When should an intravascular catheter be removed from the care plan?
CDC recommends promptly removing an intravascular catheter that is no longer essential. A device should therefore have an ongoing indication, not remain solely because it is already present or might be useful later. Balance removal with a realistic review of upcoming treatment needs. Removal itself requires the appropriate procedure and assessment for complications; the VACC outline includes PICC length, patient tolerance and site care. Do not confuse ending the indication with permission to ignore a difficult or abnormal removal.
Apply it
A patient's intravenous treatment has ended, oral therapy is established and no further vascular-access indication remains. You confirm the plan and arrange appropriate catheter removal rather than keeping it indefinitely for possible future convenience.
Common pitfall: An unused device still exposes the patient to complications. Conversely, routine removal should not proceed through unexpected resistance as though the procedure were uncomplicated.
Summary of Recommendations: Intravascular Catheter-Related Infections · 2025 Job Analysis: Appendix K. Approved Test Specification
Troubleshooting Complications and Interventions16%
42.How does suspected venous thrombosis differ from lumen occlusion or local phlebitis?
A lumen occlusion describes impaired flow through the catheter; suspected venous thrombosis concerns the surrounding vascular pathway. New diffuse arm swelling requires prompt assessment even when a PICC still flushes, because preserved catheter flow does not establish normal venous drainage. Local phlebitis instead produces inflammatory findings such as warmth, tenderness, redness or a palpable venous cord. Compare symptoms and limb findings with baseline and arrange appropriate vascular evaluation when thrombosis is suspected. These distinctions direct investigation without treating one symptom as a definitive diagnosis.
Apply it
One patient has whole-arm swelling with preserved flushing; another has tenderness, redness and a palpable cord along a peripheral vein. The first needs assessment for a vascular complication, including thrombosis. The second needs peripheral-catheter removal and assessment for phlebitis.
Common pitfall: Restoring catheter lumen flow does not treat or exclude thrombosis surrounding the device. Local redness alone also does not establish deep-vein thrombosis or bloodstream infection.
Summary of Recommendations: Intravascular Catheter-Related Infections · Patency management algorithm for central venous access devices · 2025 Job Analysis: Appendix K. Approved Test Specification
43.What are the initial actions for suspected vesicant extravasation?
Infiltration involves unintended delivery of a nonvesicant outside the vascular pathway; extravasation involves an agent capable of significant tissue injury. Burning, pain or swelling during vesicant administration therefore requires immediate action. Stop the infusion and retain access initially so residual drug can be aspirated as directed. Do not flush, because this can increase tissue exposure. Activate the clinical response and identify the agent. Subsequent removal, antidote, compress and follow-up decisions depend on the drug, device and assessment.
Apply it
A patient develops burning and swelling during peripheral vesicant administration. You stop the infusion, leave the catheter available for aspiration and obtain the extravasation resources, avoiding the routine impulse to flush or immediately discard the access.
Common pitfall: Flushing to test patency may increase tissue exposure. Immediate catheter removal can also eliminate the opportunity to aspirate residual drug through the existing access.
Algorithm: Extravasation management of intravenous anti-cancer therapies
44.How do agent-specific extravasation pathways differ, including conflicting taxane recommendations?
For vincristine, eviQ pairs hyaluronidase with warmth to promote tissue dispersion. For doxorubicin, its cold-compress and topical dimethyl sulfoxide (DMSO) pathway localizes exposure while providing treatment. Dexrazoxane is an alternative for anthracycline extravasation: initiate within six hours, avoid concurrent DMSO and remove cooling at least 15 minutes before administration to support blood flow to affected tissue. Taxane recommendations differ. Cancer Institute NSW's eviQ procedure, version 2 dated October 16, 2023, recommends no compress when hyaluronidase is selected for paclitaxel or docetaxel. The Oncology Nursing Society and American Society of Clinical Oncology guideline, published online September 18, 2025, supports warmth with hyaluronidase for these taxanes. Its antidote and thermal-compress recommendations are conditional and based on very low-certainty evidence. This guide selects that ONS/ASCO taxane pathway for the application case; it does not imply consensus. [ONS/ASCO guideline](https://ascopubs.org/doi/abs/10.1200/OP-25-00579?af=R).
Apply it
After initial extravasation measures, use hyaluronidase with warmth for vincristine. For paclitaxel or docetaxel, the selected ONS/ASCO pathway also pairs hyaluronidase with warmth. For doxorubicin treated with dexrazoxane, begin within six hours, remove cooling at least 15 minutes beforehand and avoid DMSO.
Common pitfall: Do not combine incompatible antidote strategies or assume every vesicant needs the same compress. The eviQ no-compress taxane pathway and the selected ONS/ASCO warmth pathway are differing recommendations; identify which pathway is being applied.
Algorithm: Extravasation management of intravenous anti-cancer therapies · Extravasation management: Clinical procedure
45.Which findings suggest peripheral-catheter phlebitis, and what action follows?
Phlebitis is inflammation of a vein. Warmth, tenderness, erythema or a palpable venous cord are discriminating findings; they differ from simply having a loose dressing or an isolated infusion-pump alarm. CDC recommends removing a peripheral venous catheter when signs of phlebitis develop. Stop using that catheter, remove it appropriately, assess the extent and associated findings, and arrange suitable access if treatment remains necessary. These local findings do not by themselves identify whether the cause is mechanical irritation, chemical injury or infection.
Apply it
A peripheral infusion still runs, but the vein has become tender and red with a palpable cord. You stop the infusion and remove the catheter rather than waiting for loss of flow. You assess for infection and reconsider the infusate, site and device before replacement.
Common pitfall: Preserved flow does not justify continued use of a peripheral catheter with phlebitis. Local inflammation is also not sufficient evidence to diagnose bloodstream infection.
Summary of Recommendations: Intravascular Catheter-Related Infections
46.How should mechanical causes of catheter occlusion be investigated?
An apparent occlusion may originate outside the vessel. Check the administration pathway for closed clamps, kinked tubing, connector problems and position-related changes before assigning a thrombotic cause. The eviQ patency algorithm separates mechanical, chemical and thrombotic pathways because their corrective actions differ. Use gentle assessment and stop when excessive resistance occurs. A mechanical check should not become repeated forceful flushing or unplanned manipulation of the catheter; unresolved dysfunction requires a comprehensive assessment of the device and patient.
Apply it
A central lumen suddenly resists injection after a dressing change. You inspect clamps, tubing and the external catheter arrangement first, then pursue further patency assessment if correcting an identified mechanical problem does not restore function.
Common pitfall: Calling every obstruction a clot can lead to unnecessary clearance treatment. Forceful flushing is not a diagnostic test and may damage an obstructed system.
Patency management algorithm for central venous access devices · Clinical procedure: Restoring patency to a central venous access device—partial and complete occlusion
47.How should a change in external PICC length be interpreted?
Measure the external catheter length and compare it with the insertion record and subsequent assessments. An unexplained change suggests migration and requires investigation; it does not directly identify the new internal tip location. eviQ recommends measuring at dressing changes and investigating migration, particularly in pediatric patients. Assess securement, symptoms and device function, and withhold a central-only infusion until the current location and suitability are established. Easy flushing cannot show that a displaced tip remains in an acceptable central position.
Apply it
A PICC's external segment is longer than its documented baseline after the dressing was pulled loose. You protect the catheter from further movement and arrange position assessment before central-only therapy, rather than accepting blood return as clearance.
Common pitfall: A length change is a warning requiring investigation, not a measurement of the final tip's exact position. Do not assume a previously confirmed tip remains correctly located.
Central venous access devices · Patency management algorithm for central venous access devices
48.Why should chemical and thrombotic occlusion be distinguished before treatment?
Chemical obstruction can follow precipitation or incompatibility, whereas thrombotic obstruction involves blood-related material. Their treatments are not interchangeable. Review recent infusions, compatibility concerns, flushing history, mechanical findings and the pattern of dysfunction before selecting a clearance intervention. The eviQ pathway requires comprehensive assessment rather than automatically treating every occlusion with a thrombolytic. Any proposed agent must also suit the device and clinical situation. Avoid empirical mixtures or repeated clearance attempts without an identified rationale and appropriate authorization.
Apply it
A lumen becomes obstructed immediately after sequential administration of potentially incompatible solutions. After checking mechanical causes, you investigate precipitation and seek the appropriate clearance plan rather than assuming that a thrombolytic addresses the likely mechanism.
Common pitfall: The most familiar clearance drug is not automatically the right intervention. A time relationship to incompatible infusions is a clue, not definitive proof of the obstruction's composition.
Patency management algorithm for central venous access devices · Clinical procedure: Restoring patency to a central venous access device—partial and complete occlusion
49.Why does fever alone not establish a catheter-removal indication?
Fever has multiple possible causes, and the presence of a central catheter does not establish that it is the source. CDC advises against removing CVCs or PICCs on the basis of fever alone. Evaluate the patient, insertion site, other possible infection sources and available diagnostic findings, with urgent escalation when the clinical condition warrants it. This recommendation prevents reflex removal without assessment; it does not justify delaying evaluation or retaining a catheter when stronger evidence supports infection-related intervention.
Apply it
A stable patient with a PICC develops fever but has no established source. You assess the device and other clinical findings and arrange the appropriate investigation rather than automatically removing the PICC or dismissing the fever.
Common pitfall: Avoid both extremes: a catheter is not automatically the source because it is present, and a normal-looking site does not exclude catheter-related bloodstream infection.
Summary of Recommendations: Intravascular Catheter-Related Infections
50.How should suspected catheter damage or central-device leakage change ongoing use?
A suspected crack, leak or fracture raises a device-integrity concern even when the catheter still functions. Stop the infusion and arrange assessment using the device identification, applicable instructions and clinical findings. Pain or swelling during central infusion can indicate a deeper leak despite a normal-looking entry site; eviQ describes device investigation, including a flow study when indicated. Repair or exchange is device specific. If vesicant leakage is suspected, also initiate the extravasation pathway. FDA instructions for the affected PowerPICC devices require removal and alternative access when fracture is confirmed.
Apply it
Pain and swelling develop during infusion through a central device, but there is no obvious external crack. You stop administration and arrange assessment of integrity and location before reuse. An easy flush or normal skin entry site does not exclude deeper leakage.
Common pitfall: Continued patency does not establish structural integrity. An improvised patch cannot restore a manufacturer-supported fluid pathway, and instructions for a recalled model must not be generalized to every catheter.
Intravascular PICC Catheter Recall: Bard Removes PowerPICC Intravascular Catheters · Extravasation management: Clinical procedure · 2025 Job Analysis: Appendix K. Approved Test Specification
Professional Development and Evidence-Based Practice8%
51.How is a central line-associated bloodstream infection rate calculated?
A central line-associated bloodstream infection rate uses the number of qualifying events divided by central-line days, multiplied by 1,000. The exposure denominator matters because units with different amounts of central-line use cannot be compared fairly using event counts alone. Apply the same surveillance definitions and denominator rules across the comparison. A calculated rate describes observed surveillance outcomes; it does not independently prove which practice caused a change or whether a specific individual infection originated from the catheter.
Apply it
A unit records four qualifying infections during 2,000 central-line days. You calculate four divided by 2,000 multiplied by 1,000, producing a rate of two infections per 1,000 central-line days for the surveillance period.
Common pitfall: Using admissions or patient-days changes the denominator and answers a different question. A lower raw infection count may simply reflect less central-line exposure.
52.How do process measures differ from outcome measures?
A process measure asks whether an intended practice occurred, such as observed adherence to connector disinfection. An outcome measure asks what happened to patients, such as infection frequency or device failure. Both are needed: improved compliance without improved outcomes may reveal implementation limits, measurement problems or other causes, while an outcome change without process information is difficult to explain. Define the measures before introducing a change and keep data collection consistent so the results can inform a useful improvement decision.
Apply it
A unit introduces a connector-care intervention. You track observed adherence as a process measure and infection rates as an outcome measure, allowing the team to examine both implementation and the subsequent patient results.
Common pitfall: A completed checklist does not itself prove fewer complications. Conversely, an unchanged outcome over a short period does not establish that staff ignored the intervention.
53.Why can an uncontrolled before-and-after study misattribute benefit?
An outcome may improve after a product is introduced because other factors changed at the same time. Cointerventions, patient mix, surveillance methods or an existing time trend can confound the apparent product effect. Cochrane's guidance on non-randomized studies emphasizes assessing such bias rather than treating temporal sequence as causation. Examine what else changed, whether comparison groups are appropriate and how outcomes were measured. A useful quality-improvement observation can justify further evaluation without establishing that one component caused the benefit.
Apply it
Infections decline after a new connector is introduced alongside staff retraining and a maintenance audit. You describe improvement in the combined program but avoid assigning the entire reduction to the connector without stronger comparative evidence.
Common pitfall: A large percentage reduction can still be confounded. Statistical significance does not separate a product's effect from simultaneous changes in training or patient care.
Cochrane Handbook, Chapter 25: Assessing risk of bias in a non-randomized study
54.How should a guideline be appraised before changing practice?
Check the guideline's date, target population, care setting, recommendation strength and supporting evidence before adopting it. A recommendation for adult short-term central catheters may not apply to neonates or a different device. Separate established recommendations from unresolved questions and additional approaches used when essential practices are insufficient. Appraisal should connect the evidence to the local patient and workflow, then identify how implementation and outcomes will be evaluated. The existence of a published recommendation alone does not establish universal applicability.
Apply it
A team cites an adult central-line recommendation to justify a pediatric device policy. You examine the population and device restrictions, identify the evidence boundary and seek guidance applicable to the proposed pediatric practice.
Common pitfall: A respected issuing organization does not eliminate population limits. Avoid turning an unresolved evidence question into either a universal recommendation or a universal prohibition.
Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update · Updated Recommendations on Chlorhexidine-Impregnated Dressings: Summary
55.Why should staff education include observed competence?
Attendance demonstrates exposure to teaching, while observed performance demonstrates whether a clinician can apply the required technique. CDC recommends education, periodic assessment of knowledge and adherence, and assignment of catheter tasks to personnel who demonstrate competence. Use realistic observation or demonstration to identify specific gaps, then provide targeted feedback and reassessment. A training program should connect learning needs with safe practice, rather than treating completion of a presentation or an annual acknowledgment as sufficient evidence of procedural ability.
Apply it
All staff completed a connector-hygiene module, but observation shows inconsistent preparation before access. You use focused demonstration, feedback and reassessment to address the performance gap rather than repeating attendance reminders alone.
Common pitfall: A completion certificate does not prove technical competence. Conversely, identifying a skill gap should lead to specific teaching rather than a vague instruction to be more careful.
Summary of Recommendations: Intravascular Catheter-Related Infections · Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update
Legal and Ethical Considerations8%
56.What makes a patient's consent voluntary and informed?
Informed consent requires an understandable discussion of the proposed intervention, its expected benefits and burdens, and reasonable alternatives, including forgoing treatment when relevant. The AMA emphasizes assessing the patient's ability to understand and make an independent, voluntary decision and documenting the discussion and decision. A signed form is evidence of documentation, not the entire ethical process. If a patient with decision-making capacity declines the device, explore concerns and alternatives without treating agreement as the only acceptable outcome.
Apply it
A patient who understands the proposed catheter declines it because of concerns about daily activities. You discuss the concerns, clarify alternatives and document the voluntary decision rather than pressuring the patient to sign the planned form.
Common pitfall: A recommendation does not remove the patient's role in deciding. AMA ethical guidance informs consent principles but does not establish every jurisdiction's legal requirements.
57.How should vascular access documentation support safe decisions?
Useful documentation records what was assessed, what was done, the patient's response and any unresolved issue requiring follow-up. The VACC outline explicitly includes routine maintenance, interventions, complications and insertion attempts. Use specific observations rather than unsupported conclusions: recording resistance and absent blood return is more informative than simply writing that a line is bad. Include relevant device identification and confirmation information when applicable. Accurate records support continuity, accountability and later evaluation; they should not conceal unsuccessful attempts or replace clinical reassessment.
Apply it
After an unsuccessful insertion, you record the attempt, relevant findings, patient response and revised plan. The next clinician can then avoid repeating an unproductive approach and understand why escalation or another site was chosen.
Common pitfall: Documenting only the final successful placement erases clinically relevant attempts and complications. A copied normal assessment can mislead later care when the device's condition has changed.
58.How should a device safety notice be applied accurately?
Match the safety notice to the actual device identifiers and distinguish instructions for unused inventory from instructions for devices already in patients. A notice may specify particular models, lots or updated handling requirements, so its scope cannot be inferred from a familiar brand name. FDA communications also support attention to device problems and reporting. Use the current applicable instructions, communicate relevant findings and preserve identifying information. Do not assume that every device in the same broad catheter category requires the same action.
Apply it
A unit receives a catheter recall notice. You compare model and lot information with stock and patient records, then apply the notice's separate instructions for affected inventory and any devices already in clinical use.
Common pitfall: A recall headline alone does not establish the correct patient action. Blanket removal or unrestricted continued use can both conflict with the notice's specific instructions.
Intravascular PICC Catheter Recall: Bard Removes PowerPICC Intravascular Catheters
59.How do scope and demonstrated competence shape professional responsibility?
Certification knowledge, professional authorization and demonstrated procedural competence are related but distinct. The VACC outline includes scope of practice, while CDC recommends assigning catheter tasks to personnel who demonstrate competence. A credential does not independently authorize every technique in every jurisdiction or organization. Before accepting a task, establish that it falls within the applicable professional role and that the required competence and support are present. When either is missing, obtain appropriate help while maintaining the patient's care needs.
Apply it
A clinician is asked to perform an unfamiliar catheter repair because they hold VA-BC certification. They verify authorization and device-specific competence, then arrange qualified assistance rather than treating the credential as permission for every access procedure.
Common pitfall: Knowledge certification is not a universal procedural license. Organizational permission also does not substitute for competence with the actual device and technique being requested.
2025 Job Analysis: Appendix K. Approved Test Specification · Summary of Recommendations: Intravascular Catheter-Related Infections
60.How can fiscal responsibility support appropriate vascular access?
Fiscal responsibility includes using supplies, equipment and time judiciously while meeting the patient's clinical needs. The official outline includes accurate charges, intentional use of time and appropriate resource use. Evaluate total care consequences rather than acquisition price alone: repeated failure, unnecessary lumens and unsupported maintenance can consume resources and harm patients. Cost-conscious care should improve the fit between the treatment need and the resources used. It should not justify omitting required infection-prevention measures or selecting an unsuitable device.
Apply it
A cheaper catheter requires more lumens than the patient needs and additional maintenance supplies. You compare the complete care requirements with a suitable simpler option rather than choosing solely by the purchase price.
Common pitfall: The least expensive item is not always the least costly care plan. Savings that depend on bypassing essential precautions are not responsible resource use.
2025 Job Analysis: Appendix K. Approved Test Specification · Summary of Recommendations: Intravascular Catheter-Related Infections
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Give greatest study emphasis to Patient Assessment and Troubleshooting Complications and Interventions while retaining deliberate coverage of all eight official domains.
- Link infusate requirements, actual tip location, lumen needs and measured catheter-to-vein ratio before recommending a device.
- Compare implanted and external devices using treatment frequency, needle access, maintenance, healing and activity needs.
- Distinguish preliminary vessel mapping, real-time guidance and confirmation of the final tip's anatomic location.
- Compare Seldinger insertion sequences, recognize large-bore arterial cannulation, correct sterile-field breaches and resolve inconclusive tip confirmation before use.
- Separate lumen dysfunction from venous thrombosis, localized phlebitis, catheter migration and structural leakage.
- Explain initial extravasation actions, agent-specific antidote and compress choices, the taxane guideline disagreement and cooling interruption before dexrazoxane.
- Connect aseptic preparation, connector hygiene, dressing condition and ongoing device necessity to preventable infection exposure.
- Separate outcome rates from raw counts, observed competence from attendance, and before-and-after association from causal evidence.
- Use the full official outline to extend study to specialized devices, additional insertion techniques and emergencies, pharmacologic interventions and topics beyond these selective concepts.
A practical preparation plan
1. Map the complete scope
Read the full eight-domain 2025 approved specification. Mark each topic as understood, partly understood or unfamiliar, including specialized access devices and procedures that receive limited attention in this guide.
2. Build a therapy-to-device explanation
For several patients, state the therapy's route requirements, expected use, vascular constraints and maintenance resources. Recommend a device and explain why plausible alternatives would be less suitable.
3. Rehearse preparation and insertion decisions
Explain the purpose of each barrier and antisepsis step. Compare the equipment and sequence of Seldinger variants, distinguish mapping from real-time guidance and identify the final tip target. Practise responding to arterial cannulation, a sterile breach or inconclusive confirmation.
4. Work through changed-function cases
Start with symptoms, site findings, external length and separate aspiration and injection findings. Distinguish mechanical or chemical obstruction from thrombosis, phlebitis, migration and leakage, then select the appropriate immediate response.
5. Use the drills diagnostically
Answer each question before reading its explanation. Record the decisive cue you missed and why each alternative was less appropriate. Revisit the related concept and use its application case to explain the decision aloud.
6. Verify learning and remaining gaps
Use the flashcards for spaced recall, teach back high-risk actions and calculate surveillance rates without notes. Return to the official outline and current primary guidance for topics that remain weak or fall outside this selective guide.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- About the Exam
- Detailed Content Outline
- 2025 Job Analysis: Appendix K. Approved Test Specification
- Vascular Access Certification and Recertification Candidate Handbook 2026
- Summary of Recommendations: Intravascular Catheter-Related Infections
- Updated Recommendations on Chlorhexidine-Impregnated Dressings: Summary
- Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update
- Use the Teach-Back Method: Tool 5
- Extravasation management: Clinical procedure
- Intravascular PICC Catheter Recall: Bard Removes PowerPICC Intravascular Catheters
- Informed Consent: AMA Code of Medical Ethics, Opinion 2.1.1
- Central venous access devices
- PowerMidline Catheter
- Address Language Differences: Tool 9
- Patency management algorithm for central venous access devices
- Clinical procedure: Restoring patency to a central venous access device—partial and complete occlusion
- Cochrane Handbook, Chapter 25: Assessing risk of bias in a non-randomized study
- Algorithm: Extravasation management of intravenous anti-cancer therapies
- 2.1.1.pdf
- 022025s019lbl.pdf
- Practice Guidelines for Central Venous Access 2020 : Anesthesiology
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.